In asthma, airway nerve dysfunction leads to excessive bronchoconstriction and cough. It is well established that eosinophils alter nerve function and that airway eosinophilia is present in 50 to 60% of asthmatics. However, the effects of eosinophils on airway nerve structure have not been established. We tested whether eosinophils alter airway nerve structure and measured the physiological consequences of those changes. Our results in humans with and without eosinophilic asthma showed that airway innervation and substance P expression were increased in moderate persistent asthmatics compared to mild intermittent asthmatics and healthy subjects. Increased innervation was associated with a lack of bronchodilator responsiveness and increased irritant sensitivity. In a mouse model of eosinophilic airway inflammation, the increase in nerve density and airway hyperresponsiveness were mediated by eosinophils. Our results implicate airway nerve remodeling as a key mechanism for increased irritant sensitivity and exaggerated airway responsiveness in eosinophilic asthma.
INTRODUCTION
Asthma is an inflammatory airway disease characterized by periods of increased bronchoconstriction and heightened sensitivity to in haled irritants (1) . These responses are controlled by an integrated network of sensory and parasympathetic airway nerves (2) . Sensory nerves detect chemical and mechanical stimuli and induce broncho constriction by activating parasympathetic nerves through a central neuronal reflex pathway (3, 4) . Reflex bronchoconstriction is clearly relevant in asthma because muscarinic antagonists that block neu ronally mediated bronchoconstriction, such as tiotropium, improve lung function and asthma symptoms (5, 6) . Eosinophils, which are a defining feature of the most common asthma phenotype, termed type 2high asthma (7) , cause excessive bronchoconstriction in part by altering parasympathetic nerve function (8) (9) (10) . This mecha nism is well established. However, whether eosinophils also affect airway sensory nerves comprising the afferent limb of the reflex arc is not fully known.
In type 2high asthma, interleukin5 (IL5) promotes eosinophil maturation, recruitment, and survival (11) . Accordingly, therapies that block IL5 rapidly reduce blood eosinophils and decrease the frequency of asthma exacerbations. However, anti-IL5 therapies only modestly reduce eosinophils within airway parenchyma (12) . These discordant responses suggest that mechanisms regulating eo sinophils in airway parenchyma are more complex than those gov erning eosinophils in the blood. For example, airway nerves control eosinophil recruitment by releasing a variety of mediators (13) (14) (15) . This phenomenon is starkly apparent in airways of severe asthmatics who died from asthma exacerbations, where more eosinophils are found clustered around airway nerves than in any other airway compartment, such as around blood vessels or within the airway parenchyma (9) .
Studying airway sensory nerves has historically been challeng ing because of the morphologic complexity of sensory nerve structure. Sensory nerves are arranged in threedimensional (3D) networks that only cover 1 to 3% of the airway epithelium yet span tens to hundreds of 5 to 15mthick histologic tissue sections (16) . Consequently, features such as nerve branching and axonal length cannot be captured in individual slices. Previous studies that attempted to quantify nerve architecture in asthma using conven tional methodology and semiquantitative manual analyses were prone to sampling error and yielded conflicting results (17) (18) (19) (20) . These studies may also have been confounded by inadequate asth ma phenotyping and comparing samples from disparate airway locations that have different nerve structures at baseline. To over come these limitations, we developed an imaging method that quantifies 3D nerve structure (nerve length and branch points) in intact, wholemount human airway specimens obtained by endo bronchial biopsy using tissue optical clearing and 3D re construction of confocal microscopy images (21, 22) . Wholemount microscopy has the advantage of more fully capturing 3D epithelial nerve structure.
Using this technique, we measured airway innervation, substance P expression, and eosinophilia in bronchial biopsies from humans with and without asthma and found that airway innervation and substance P expression were increased in moderate persistent asth matics compared to mild intermittent asthmatics and healthy subjects. The increase was most evident in patients with airway and periph eral blood eosinophilia and was associated with a lack of broncho dilator responsiveness and an increased sensitivity to inhaled irritants. Airway innervation was also increased in Il5overexpressing trans genic mice with airway eosinophilia, and these mice had airway hyper responsiveness that was mediated by increased airway inner vation. Crossing Il5overexpressing mice with mice congenitally deficient in eosinophils yielded mice with high airway Il5 but no eosinophils. These mice had neither increased airway innervation nor hyperresponsiveness, indicating that eosinophils, not Il5, are responsible for these changes. These results suggest that eosinophil induced airway nerve remodeling might play a key role in lung func tion impairment in eosinophilic asthma.
RESULTS
Moderate persistent asthma is associated with worse lung function and lower quality of life Sixtythree patients were included in the final analysis and were grouped by asthma treatment status per Expert Panel Report 3 Asthma Management criteria (23) . Mild intermittent asthmatics were treated only with shortacting bronchodilators as needed. Moderate persistent asthmatics were patients who required long acting inhaled controller medications, including an inhaled cortico steroid. Nonatopic, nonsmoking subjects free of existing lung disease served as healthy controls. Age, sex, and body mass index were similar between groups (Table 1 ). Moderate persistent asthmatics had higher blood eosinophil counts, lower forced expiratory volume in 1 s (FEV1), and lower FEV1/forced vital capacity (FVC) ratios than mild intermittent asthmatics and healthy controls. Moderate persistent asthmatics also reported more asthma related symptoms, which were reflected in lower Asthma Quality of Life Questionnaire (AQLQ) scores compared to mild intermittent asthma (Table 1) .
Airway innervation is increased in moderate persistent asthma
Airway nerve length and the number of nerve branch points in hu man lungs were quantified using immunofluorescence and 3D nerve modeling in biopsies from the right middle lobe bronchus (Fig. 1A and movies S1 and S2). Moderate persistent asthmatics had signifi cantly increased nerve length (Fig. 1B) and increased nerve branch ing (Fig. 1C) compared to mild intermittent asthmatics and healthy nonasthmatic controls (*P < 0.05). Nerve length and branching were similar between mild intermittent asthmatics and control sub jects (Fig. 1, B and C). Individuals with longer nerves tended to have more branch points, indicating that neuronal growth and arboriza tion occur concurrently (r 2 = 0.87, *P < 0.0001; Fig. 1D ). Sensory nerve substance P expression was also increased in moderate per sistent asthma compared to mild intermittent asthma and controls (*P < 0.05; Fig. 1E and movie S3). *The body mass index is the weight in kilograms divided by the height squared. †P < 0.05 compared to control. ±P < 0.05 compared to all other groups. §Minimally important differences are reflected by differences in scores >0.5 points.
Airway and blood eosinophils are associated with increased airway innervation Airway eosinophils were labeled with an antibody against eosinophil peroxidase. Total eosinophil peroxidase-positive voxels were quanti fied 20 m above and 20 m below the airway epithelial basement membrane. Moderate persistent asthmatics had increased eosinophil peroxidase both above and below the epithelial basement membrane compared to mild intermittent asth matics and control subjects (*P < 0.05; Fig. 2A ). Within individual subjects, the number of blood eosinophils measured at the time of airway sampling did not correlate with the amount of airway eo sinophil peroxidase (r 2 = 0.01, P = 0.8; Fig. 2B ).
Subjects with a type 2high asthma phenotype, defined as blood eosinophils greater than 300 cells/l (24) , had longer airway nerves (Fig. 2C ) and increased nerve branch points (Fig. 2D ) compared to control airways (*P < 0.05). In contrast, nerves in type 2low asthmatics with blood eosinophils less than 300 cells/l were not significantly different from healthy subjects (Fig. 2, C and D) . Type 2high and type 2low asthmatics were further stratified on the basis of the amount of eosinophil peroxidase present within airway parenchyma. Nerve length ( Fig. 2E ) and branch points ( Fig. 2F) were similar between type 2low asthmatics and con trol subjects irrespective of their amount of airway eosinophil peroxidase. How ever, a portion of type 2low asthmatics were found to have increased airway eo sinophil peroxidase. Moreover, in patients with moderate persistent asthma, the amount of eosinophil peroxidase posi tively correlated with nerve branch points but not with nerve length (r 2 = 0.14, *P < 0.05 and r 2 = 0.1, P = 0.09, respectively; Fig. 2 , G and H). In mild intermittent asthmatics, eosinophil peroxidase did not correlate with nerve length (P = 0.45) or branch points (P = 0.77).
Airway innervation is associated with irritant sensitivity and worse quality of life
We next tested the association between airway nerve structure and pulmonary function. Nerve length and number of branch points were not different between asthmatics with and without airflow ob struction (Fig. 3, A and B) . A subgroup of patients received an inhaled broncho dilator (shortacting  agonist and/or muscarinic antagonist) before repeating spirometry to assess for bronchodilator responsiveness. A "positive bronchodilator response" was defined as a greater than 200 ml increase in expiratory volume that repre sented a >12% improvement from their prebronchodilator result. Increased nerve branching, but not nerve length, was associated with a lack of bronchodilator responsiveness (*P < 0.05 and P = 0.053, respectively; Fig. 3 , C and D). Increased sensitivity to inhaled irritants, defined as moderate or worse sensitivity (score 5 or less) 
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Representative 3D nerve models generated from bronchoscopic human airway biopsies obtained from healthy subjects (control) and patients with mild intermittent asthma (intermittent) and moderate persistent asthma (persistent), immunolabeled with antibody to neuronal substance P, and the panneuronal protein PGP9.5. Movies of nerve modeling are available in the online supplement (movies S1 to S3). Data are presented as means ± SEM. Asterisk (*) indicates P < 0.05 compared to all other groups. Statistical significance was determined using one-way analysis of variance (ANOVA) with a Bonferroni post hoc test (B, C, and E) and linear regression (D). In total, 63 subjects were included in the final analysis. Three biopsy specimens were analyzed per subject with 10 randomized z-stack images obtained per specimen.
on the Asthma Quality of Life Question naire, was associated with longer nerve length (*P < 0.05; Fig. 3E ) but not with increased branching (P = 0.055; Fig. 3F ).
Airway innervation is not associated with a patient's sex, age, or body habitus Airway nerve length and branching were evaluated in asthma patients stratified by sex, body mass index, and age to determine whether nerve morphology was associated with a patient's demo graphics or body habitus. Nerve length and branching were similar between men and women within each asthma cohort ( fig. S1 , A and B) and were unre lated to body mass index (fig. S1, C and D). Age also did not correlate with airway innervation (branching and length r 2 = 0.003, P = 0.23 and r 2 = <0.005, P = 0.7, respectively; fig. S1, E and F).
Eosinophils increase epithelial innervation and neuronal reflex bronchoconstriction in mice
To test whether eosinophils alter airway nerve structure and to define the conse quences of those changes, we evaluated nerve morphology and airway respon siveness using transgenic mice with eo sinophilic airway inflammation induced by Il5 overexpression in respiratory epi thelium (Il5tg) (25) . These mice were com pared with wildtype (WT) mice, with eosinophildeficient (PHIL) mice (26) and with crossed Il5tg/PHIL mice (with elevated Il5 and eosinophil deficiency) to discriminate the effects of eosinophils from those of Il5. Increases in airway resistance in response to aerosolized serotonin were recorded with intact va gus nerves to measure neuronal reflexmediated bronchoconstriction. In WT mice, serotonin induced minimal bron choconstriction. In contrast, Il5tg mice had significantly increased broncho constriction in response to aerosolized serotonin (*P < 0.05 compared to all other groups; Fig. 4A ). Serotonininduced bronchoconstriction in Il5tg mice was eliminated by vagotomy, demonstrating that bronchoconstriction was mediated by a neuronal reflex (Fig. 4B) . Eosinophil deficient PHIL mice and Il5tg/PHIL mice had similar airway responsiveness com pared to WT mice (Fig. 4, A and B) , in dicating that eosinophils, not Il5, mediate airway hyperresponsiveness. Nerve length and branch points in patients stratified into terciles by peripheral blood eosinophil count. n = 62 subjects. (E and F) Nerve length and branch points in subgroups stratified by type 2 asthma phenotype and airway EPX. Type 2-low versus type 2-high asthma was defined by blood eosinophils less than or greater than 300 cells/l. High EPX was defined as greater than 5500 positive voxels. n = 57 subjects.
(G and H) Correlation of nerve length (G) and branch points (H) with airway EPX in patients with moderate persistent asthma. Linear regression for length r 2 = 0.1 and P = 0.09 and for branch points r 2 = 0.14 and P < 0.05. n = 28. Bar graphs represent means ± SEM. Asterisk (*) indicates P < 0.05. Statistical significance was determined using one-way ANOVA with a Bonferroni post hoc test (A and C to F) and linear regression.
Il5tg mice with airway eosinophilia also showed increased epi thelial nerve length and branching in both the proximal trachea (*P < 0.05 compared to all other groups; Fig. 4 , C and D, and table S1) and at the carina (*P < 0.05 compared to all other groups; Fig. 4, E and F) . Airway nerve length and branching in eosinophildeficient PHIL mice and Il5tg/PHIL mice were similar to controls (Fig. 4, C to F) . Bron choalveolar lavage was used to confirm the presence or absence of airway eosinophils. As expected, Il5tg mice had significantly more eosinophils compared to all other groups (Fig. 4G) .
DISCUSSION
Here, we report that airway epithelial sensory nerves undergo sub stantial structural remodeling in eosinophilic asthma that manifests as increased airway nerve density. We also show that airway eosin ophils increased epithelial sensory innervation and neuronally me diated airway responsiveness in a transgenic mouse model. These findings define a critical link between eosinophilic inflammation and airway nerve growth and suggest that sensory neuroplastic ity may contribute to heightened symptoms and worse lung function in asthma.
Distinguishing asthmatics with increased innervation may be clinically relevant given that this phenotype is associated with in creased sensitivity to environmental stimuli and may preferentially benefit from therapies targeting neuronal reflex bronchoconstriction, such as muscarinic antagonists (27) . This subgroup's potentially unique response to therapies targeting eosinophilnerve interactions should also be considered when designing future clinical trials. To this point, our data show that airway eosinophilia correlates with increased airway innervation and that some type 2low asthmatics (defined by low blood eosinophils) have elevated airway eosinophils. Thus, phenotyping eosinophilic asthma patients using blood eosinophil counts, as was common in many recent asthma trials, may overlook this population of patients who could benefit from eosinophil targeting therapies.
Nerve morphology is not currently used to stratify asthma phe notypes. However, quantitative measurement of sensory nerve den sity and morphology in skin biopsies has diagnostic and prognostic utility for diseases involving aberrant nerve function, such as pain hypersensitivity (28) . A similar approach using tissue optical clear ing to characterize airway epithelial sensory neuroplasticity may be useful in the lungs. 3D nerve modeling has been used to describe airway nerve subtypes in healthy human lungs (16) and demon strated that airway innervation increased in response to allergen and ozone exposure in rhesus monkeys (29) . Our study further sup ports the feasibility of this technique. Our analysis intentionally limited evaluation of innervation to endobronchial samples from the bifurcation of the right middle lobe bronchus to target a loca tion enriched for airway sensory nerves and to limit confounding from natural variations in nerve density at different airway loca tions (21, 22) .
Airway nerve growth primarily involved axons expressing sub stance P. Substance P is a neuropeptide that lies at the nexus of neu roimmune interactions in the airways given its ability to recruit and activate eosinophils (30) , increase nerve sensitivity (31), induce phenotypic switching of sensory nerve subpopulations (32) , and stimulate airway smooth muscle contraction (33) . Previous studies reported increased substance P in airway epithelium and broncho alveolar lavage from asthmatics (34, 35) . However, drugs designed to block substance P in asthma have had limited efficacy in clinical trials (36) (37) (38) , possibly due to inadequate patient phenotyping or because unanticipated changes in substance P signaling occur in asthma, such as alterations in the sensitivity of substance P recep tors neurokinin 1 (NK1) and neurokinin 2 (NK2), or changes in substance P metabolism by neutral endopeptidase.
Substance P is one of several neuropeptides [neurokinin A and calcitonin gene-related peptide (39, 40) ] and chemokines [eotaxin (41) ] that actively recruit eosinophils to the lungs and specifically to airway nerves. As a result, eosinophils are found clustered around nerve fibers and parasympathetic ganglia in histologic sections of airways from animals after antigen or ozone exposure (9, 41, 42) and in airways of humans who died of asthma (9) . When eosinophils phys ically interact with nerves, granule proteins are released, which alter nerve function and promote airway hyperresponsiveness (43) (44) (45) (46) (47) . For example, eosinophil major basic protein stimulates transient receptor potential V1 (TRPV1) expression in sensory nerves in vitro (48) , which may explain why asthmatics have increased sensitivity to TRPV1 agonists (49) . Major basic protein is also an allosteric antagonist of M 2 muscarinic receptors on parasympathetic nerves (50) . Loss of M 2 function results in excessive parasympathetic nerve acetylcholine release and potentiation of bronchoconstric tion. This mechanism is observed after virus infection (51), ozone in halation (52) , organophosphorus pesticide exposure (53) , and after antigen sensitization and challenge in experimental models (8, 54) . Loss of neuronal M 2 receptor function has been documented in asthmatic humans as well (55, 56) .
Although our data show a positive correlation between airway eosinophil peroxidase and increased innervation, the specific medi ator(s) driving nerve growth in human airways remains unknown. Other eosinophil granule proteins (major basic protein and eosino phil cationic protein) and/or eosinophilderived neurotrophins may be responsible for sensory nerve growth (57, 58) . In a previous study, blocking the neurotrophin nerve growth factor was insuf ficient to prevent eosinophilinduced nerve growth in cutaneous sensory nerves (59) , suggesting that other neurotrophins such as brain derived neurotrophic factor or neurotrophin3 may be involved, or that considerable redundancy exists in this system. Eosinophil per oxidase and major basic protein have also been linked to nerve pro liferation and survival, albeit in a neuroblastomabased model of cholinergic neurons (60) (61) (62) (63) . However, in contrast to our findings in sensory nerves, granule proteins reduced cholinergic nerve length in this in vitro model (64) . It is also possible that eosinophils exert their effects by altering cytokine or neurotrophin release from neigh boring cells close to nerves, such as respiratory epithelium or sat ellite glial cells.
Close proximity of eosinophils to nerves is critical for the devel opment of neuronally mediated airway hyperreactivity. Accordingly, treatments that prevent eosinophil recruitment to airway nerves, such as antibodies against eosinophil surface receptors CC chemokine receptor type 3 (41) and very late antigen4 (65) , and corticosteroids (66, 67) , preserve nerve function and prevent neuronally mediated air way hyperreactivity in animal models. However, the longterm ef fects from preventing eosinophil nerve interactions in the airways have yet to be studied. Thus, the critical question remains whether neuro nal remodeling is a reversible process. In skin, topical application of capsaicin or lidocaine decreases epidermal nerve density (68, 69) , sug gesting that changes in nerve density are dynamic and might be tar geted therapeutically. A similar approach targeting structural changes in airway sensory nerves, in combination with blockade of nerve function, may be beneficial in asthma.
In this regard, newer therapies that block the IL5 pathway might be effective in preventing eosinophilnerve interactions. Antibodies against IL5 (mepolizumab and reslizumab) and IL5 receptors (benralizumab) produce rapid and profound reductions in circulating eosinophils and reduce the frequency of exacerbations in type 2high asthma (11) . Anti-IL5 antibodies also reduce the number of airway tissue eosinophils and eosinophils physically asso ciated with airway nerves in animals (42) , although in the case of mepolizumab, a more modest reduction in airway tissue eosinophils was seen in an early human trial (12) . The newest of these agents, benralizumab, produces the largest reduction in circulating eosino phils in this drug class and, unlike other anti-IL5 agents, improves expired airflow on spirometry, possibly indicating that benralizumab improves neuronal dysfunction as well.
Our data indicate that airway innervation does not correlate with body habitus (obesity) or female gender, which are both character istics associated with specific asthma phenotypes (70) . However, our study could not assess all demographic and environmental variables that are potentially related to increased airway innervation. Further more, because our study assessed innervation at a single time point, our data are unable to illuminate when pathologic nerve growth begins. That said, our data do suggest that nerve growth is not a function of normal aging in adults, which contrasts with lung develop ment during childhood when airway innervation increases between infancy and adolescence (71) .
In sum, our data indicate that airway nerves contribute to asth ma pathology. We have shown that moderate persistent asthmatics have increased airway sensory innervation that is especially marked in asthmatics with accompanying eosinophilia. The role of eosino phils in neuronal remodeling and the effects of remodeling on airway hyperreactivity are confirmed in mice. It is possible that increased sensory innervation represents a unique asthma phenotype that may respond to drugs targeting eosinophils or their proteins, or drugs that interrupt the neuronal reflex arc such as anticholinergics.
MATERIALS AND METHODS

Study design
This study was designed to evaluate airway sensory innervation and eosinophilia in humans with and without asthma and to characterize the physiologic consequences of eosinophil and airway nerve inter actions using transgenic mice. To this end, confocal microscopy and 3D nerve modeling were used to quantify nerve morphology (nerve length and branching), neuropeptide expression, and eosinophils in immunofluorescently labeled, optically cleared airway specimens obtained by endobronchial biopsy. In total, 63 subjects were included in the final analysis. Three biopsy specimens were analyzed per sub ject with 10 randomized zstack images obtained per specimen. Sam ple sizes were chosen on the basis of nerve morphology pilot data.
Airway sensory nerve morphology and airway responsiveness to aerosolized serotonin were measured in mice that overexpressed Il5 in airway epithelium (Il5tg), in eosinophildeficient mice (PHIL), in eosinophildeficient mice with Il5 overexpressed in airway epithelium (Il5tg/PHIL), and in WT mice before and after vagotomy to define neuronally mediated bronchoconstriction. Researchers were blinded to experimental conditions when conducting experiments and through out the analysis of results.
Patient recruitment
Eligible patients were ≥18 years old. Subjects provided written in formed consent. The protocol was approved by the Institutional Review Board of Royal College of Surgeons (Dublin, Ireland). Med ication use, pulmonary function testing, blood eosinophil counts, serum immunoglobulin E (IgE) levels, and smoking history were obtained. Subjects with asthma completed the Asthma Quality of Life Questionnaire to assess asthma burden across four domains (symptoms, activity limitation, emotional function, and environ mental exposure) using a sevenpoint Likert scale with higher scores indicating better quality of life (72) . Minimally important differences were indicated by a greater than 0.5 difference in overall score and within each individual domain. Animals C57BL/6 mice (8 to 12 weeks old, male and female; Jackson Lab oratory), transgenic mice overexpressing Il5 driven by an airway epithelium-specific promoter (Il5tg; NJ.1726 line) (25) , and eosinophil deficient mice (PHIL line) (26) were maintained by backcrossing on a C57BL/6 background, housed in a pathogenfree environment, and han dled in accordance with the U.S. Animal Welfare Act as set forth in Na tional Institutes of Health guidelines. Eosinophil deficient mice with elevated airway Il5 were also generated by crossing Il5tg mice with PHIL mice (Il5tg/PHIL line). Protocols were approved by the Institutional Ani mal Care and Use Committee of Oregon Health and Science University.
Airway sampling
Human bronchial biopsies (three to five per subject) were taken from the bifurcation of the right middle lobe and immediately fixed in formalin overnight. Mouse lungs were removed en bloc and fixed in Zamboni's fixative overnight. After fixation, samples were washed in phosphatebuffered saline and stored in 70% ethanol.
Immunohistochemistry
Tissues were immunostained at 4°C on a shaker. Tissues were washed with pH 7.4 trisbuffered saline (TBS) and then blocked overnight with 4% normal goat serum, 1% Triton X100, and 5% powdered milk in TBS. Airway nerves were labeled with rabbit polyclonal antibody against panneuronal marker PGP9.5 (protein gene product 9.5) (Millipore) and with rat polyclonal antibody against substance P (BD Pharmingen), followed by Alexa Fluor anti rabbit 488 and antirat 555 secondary antibodies (Life Technologies). Eosinophils were labeled with an antibody against eosinophil perox idase, followed by Alexa Fluor antimouse 647 secondary antibody (Life Technologies). No primary, rat IgG, and rabbit IgG controls were run in parallel. Tissues were dehydrated with methanol and then rendered transparent via optical clearing using benzyl alcohol and benzyl benzoate [1:2 (v/v)]. Samples were mounted in medium containing the nuclear counterstain DAPI (4′6diamidino 2 phenylindole, dilactate; Molecular Probes) on well slides (1 mm thick) and sealed with Permount (Thermo Fisher Scientific) under neath a glass coverslip (60 mm × 22 mm × 0.15 mm).
Image acquisition and processing
Images were acquired using a Zeiss LSM780 confocal microscope and 63×/0.45 PlanApo objective with a 2mm working distance (Carl Zeiss). The inplane (x and y) and outofplane (z) resolution was 0.264 m × 0.264 m × 1.00 m. Ten randomized images were taken of each human biopsy using DAPI to locate the epithelium. The total inplane field of view and scan depth for a single human biopsy zstack image acquisition was ~135 m × 135 m × 80 m.
3D mapping and quantification of airway epithelial nerves
Airway nerves were modeled in 3D with commercially available im age processing software that uses adaptive contour fiber tracking to generate bestfit tubular nerve models between userdefined con trol points (Imaris). Users were blinded to study group at the time of nerve modeling. Nerve length, nerve branch points, and eosino phil peroxidase-positive voxels were quantified within 20 m of the airway epithelial basement membrane. Elevated airway eosinophil peroxidase was defined as greater than 5500 arbitrary units (1.5 times the interquartile range of control eosinophil peroxidase added to control mean). Neuronal substance P expression was quantified on the basis of colocalization of substance P-positive voxels within PGP9.5positive nerve axons.
Airway physiology
Mice were anesthetized with ketamine (100 mg/kg) and xylazine (5 mg/kg) intraperitoneally, paralyzed with succinylcholine (5 mg/kg), and ventilated via a tracheal cannula (125 breaths/min; tidal vol ume, 0.3 ml; positive endexpiratory pressure, 2 mmH 2 O). Airway peak pressures during ventilation and airway plateau pressures obtained at the end of a 0.2s inspiratory pause were measured via an inline pres sure transducer at baseline and after escalating doses of aerosolized serotonin (5HT; 10 l at 1 to 100 mM; Aeroneb). Airway resistance was calculated as the difference between peak pressure and plateau pres sure divided by the inspiratory flow. In separate experiments, the vagus nerves were surgically ligated to eliminate neuronal reflex bronchoconstriction, and a serotonin dose response was performed.
Statistical analysis
Nerve length and branching were analyzed using a oneway ANOVA with a Bonferroni post hoc test and by linear regression. Dose responses were analyzed using twoway ANOVA for repeated measures. Baseline characteristics and cell counts were analyzed using oneway ANOVA with a Bonferroni post hoc test. All statistics were analyzed using GraphPad Prism 7 (GraphPad), and data are presented as means ± SEM.
SUPPLEMENTARY MATERIALS
www.sciencetranslationalmedicine.org/cgi/content/full/10/457/eaar8477/DC1 Fig. S1 . Airway innervation was not associated with sex, body mass index, or age. Table S1 . Raw data of airway nerve modeling and eosinophilia in mice. Movie S1. Quantitative 3D model of airway epithelial sensory nerves from a healthy nonasthmatic subject. Movie S2. Quantitative 3D model of airway epithelial sensory nerves from a subject with moderate persistent asthma. Movie S3. Quantitative 3D model of airway epithelial sensory nerves costained for substance P from a subject with moderate persistent asthma.
